DOCSLIB.ORG

Download, Print and Save Electronic Copies of Whole Works for Their Own Personal Non-Commercial Use

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

- 1 - - 2 - Abstract Human centromeres contain large arrays of α-satellite DNA that are thought to provide centromere function. These arrays show size and sequence variations. However, the lower limit of the sizes of these DNA arrays in normal centromeres is unknown. Using a set of chromosome-specific α-satellite probes for each of the human chromosomes, interphase Fluorescence In Situ Hybridisation (FISH) was performed in a population screening study. This study demonstrated that extreme reduction of chromosome-specific α-satellite is unusually common in chromosome 21 (screened with the αRI probe), with a prevalence of 3.70%, compared to ≤0.12 % for each of chromosomes 13 and 17, and 0 % for the other chromosomes. No analphoid centromere was identified in over 17,000 morphologically normal chromosomes studied. All the low- alphoid centromeres are fully functional as indicated by their mitotic stability and binding to centromere proteins including CENtromere Protein-A (CENP-A), CENtromere Protein-B (CENP-B), CENtromere Protein-C (CENP-C), and CENtromere Protein-E (CENP-E). Sensitive metaphase FISH analysis of the low-alphoid chromosome 21 centromeres established the presence of residual αRI as well as other non-αRI α-satellite DNA suggesting that centromere function may be provided by (i) the residual αRI DNA, (ii) other non-αRI α-satellite sequences, (iii) a combination of i and ii, or (iv) an activated neocentromere DNA. These low-alphoid centromeres contained 51-184 kb (mean = 78 kb) of α-satellite, determined using a novel Quantitative-FISH (Q-FISH) methodology. Further delineation of the boundaries of CENP-A binding domain and the small α- satellite array, however, has been hindered by the low resolution offered by fluorescence microscopy and the lack of genomic markers. Neocentromeres belong to a different class of centromeres formed at interstitial genome segments. They are characteristically devoid of highly repetitive sequences. CENP-A is a histone H3 homologue thought to be essential for proper centromere formation. CENP-A binds to the centromere DNA and is proposed to organise DNA into specialised nucleosomal structure. This centromere-specific chromatin is essential for the - 3 - nucleation and the functioning of a centromere. Using the 10q25.2 neocentromere on the marker chromosome mardel(10) as a model system, a combined chromatin- immunoprecipitation and Bacterial Artificial Chromosome (BAC) genomic array- screening procedure, called Functional And Structural Topography Scanning Along ChromosomeS (FASTSACS), was developed to study the centromere chromatin. A region of ~350-kb CENP-A-binding domain was defined. This domain shows a depletion of normal histone H3 but not histone H4, providing in vivo evidence for the existence of specialised nucleosomes at the neocentromere. Changing acetylation status using the histone deacetylase inhibitor Trichostatin A (TSA) results in a unidirectional shift of the CENP-A domain to an adjacent position 300-400 kb away, with no significant alteration in the size of the domain or overt effect on neocentromere activity. These data suggest an optimal size requirement for the CENP-A-binding domain and provide the first example of in vivo inducible centromerisation of a previously non-centromeric DNA. - 4 - Declaration This is to certify that, (i) the thesis comprises only my original work, except where indicated in the preface and acknowlegements, (ii) due acknowledgment has been made in the text to all other materials used, (iii) the thesis is less than 100,000 words in length, exclusive of tables, maps, bibliographies and appendices. Wing Ip Anthony Lo September, 2000 - 5 - Preface I would like to acknowledge the following people that have significantly contribute to this work. Alpha-satellite clones (pZ5.1, pX2, pAE0.68, p4n1/4, pEDZ6, pZ7.5, pZ8.4, pMR9A, pZ10-2.3, pB12, pZ16A. pZ20, pLAX and pLAY5.5) were obtained from Dr. M. Rocchi. The probe αRI, αXT (Jorgensen et al. 1987) and L1.84 (Devilee et al. 1986) were gifts from the respective authors. Clones pTRA-20, TR-17 and pTRA-7, were generated by Dr. K.H.A. Choo. BAC clone E8 was identified by Dr. M.R. Cancilla with Ms K. Tainton. Dr. R. Saffery and Dr. K.H.A. Choo, with the technical assistance of Mr. A.K. Aung, Ms. B. Griffiths, Ms. D.V. Irvine and Ms. A. Stafford, produced the 10q25.2 contig map and provided the glycerol stocks of the selected BAC clones. Anti-mouse CENPA, anti-human CENP-A and anti-CENPC antibodies were produced by Dr. P. Kalitsis. Anti-mouse CENPB antibody was a gift from Dr. D. Hudson. Anti-human CENP-E antibody was a gift from Dr. T.J. Yen. The somatic cell hybrid, WAVR-4d-F9-4a, was a gift from Dr. R.H. Riddle. The cell lines, BE2C1-18-1f and BE2C1-18-5f, were produced by Dr. D. du Sart. The combined effort of Dr. K.H.A. Choo, Ms. M.E. Earle and Mr. G.C.-C. Liao significantly contributed to approximately 5 % of the interphase FISH screening for low- alphoid/analphoid centromeres. Cytogenetic analysis and specimen preparations were performed by the staff of the Victorian Clinical Genetics Services as part of their routine clinical laboratory services. Retrieval and re-freezing cell lines in Phase II studies were performed by the staff of Tissue Culture Facilities of the Murdoch Childrens Research Institute operated by Ms. M. Crawford. - 6 - Dr. J.M. Craig performed cell preparation and counting in the mitotic analysis of the marker chromosome mardel(10) in the study of the effect of trichostatin A to the CENP- A binding domain in neocentromere. This work has been accredited by the Royal College of Pathologists of Australasia (RCPA) and the Hong Kong College of Pathologists (HKCP) as training, equivalent for 2 years and 1 year, respectively. - 7 - Acknowledgments I would like to thank all the wonderful people in the Murdoch Childrens Research Institute for creating such a stimulating environment for quality research. I thank the support of University of Melbourne and MCRI for offering me the Melbourne International Research Scholarship, International Postgraduate Research Scholarship and an MCRI award. My special thanks also go to the director of MCRI, Prof. Bob Williamson, who has been very encouraging since I first applied for Ph.D. to MCRI in early 1996. I am very grateful to my supervisor, Dr. K.H. Andy Choo, for all his help throughout these 3.5 years, being very understanding and most importantly, directing a research team which is both friendly, resourceful and powerful. I would also like to thank members of my Ph.D. committee: Dr. P. Ioannou (chairman), Dr. S. la Fontaine (1997- 98), Dr. A. McCall (1998-99), Dr. J. Mercer (1997-98), Dr. K. Nararyanan, Dr. D. Newgreen (1999-2000) and Dr. H. Slater. Hearty thanks to all the past and present laboratory members of the Chromosome Research Group who have constituted such a great team and making me proud to be associated with. Special thanks to Dr. Suzi Cutts, Ms. Liz Earle and Dr. Lee Wong, who have been advising me on a lot of my everyday technical challenges. Besides those acknowledged in the “Preface” for contribution to the work reported in this publication, collaboration works have been set up with nearly all the members of the laboratory, from whom I have learned a lot and be most grateful, 1. Production of HAC from chromosome 21 with Dr. Richard Saffery; 2. Study of truncation product on mardel(10) with Mr. Andrew MacDonald; 3. Characterisation of telomere and α-satellite in a bottom-up E8 HAC with Dr. Michael Cancilla, Dr. Suzi Cutts, Ms. Linda Hii and Ms Kelly Tainton; 4. Study of a ring marker chromosome 1p32-p36.1 with Ms. Liz Earle; 5. Study of a chromosome 21 with diminished heterochromatin at the centromere with Ms. Anne Robertson (VCGS); - 8 - 6. Characterisation of mouse CENPA/GFP embryonal stem cells with Ms. Saara Redwood and Dr. Emily Howman; 7. Characterisation of Cenpf knock out mouse with Ms. Kerry Fowler and Dr. Richard Saffery; 8. Mapping of mouse Cenph gene with Ms. Kerry Fowler and Mr. Dave Longmuir; 9. Study of histone acetylation status of the 10q25.2 neocentromere with Dr. Alyssa Barry and Dr. Jeff Craig; 10. FASTSACS to identify the neocentromere on invdup(20p) with Dr. Dianna Magliano and Ms. Mandy Sibson; 11. Characterisation of a chromosome 18 derived marker chromosome with Dr. Jane Craig and Dr. Howard Slater (VCGS). Special thanks also to Prof. Ed Janus who acted as my clinical supervisor from 1997- 99 and offered me a post of “Honorary Registrar” in the core laboratory of Clinical Biochemistry of the Royal Children’s Hospital for continuation of my training for FRCPA and FHKCP. Thanks to Ms. Wai Kit Lam for producing the originals of the images of my wife, Dr. Wai Ming Lam. Finally, I would also like to thank Ms Sarah Chan, Dr. J. Craig and Dr. R. Saffery for critical reading of this thesis and helpful discussions. awilo 16th September, 2000 Melbourne, Australia - 9 - Brief Table of Contents Abstract........................................................................................................................1 Preamble .................................................................................................................... 22 CHAPTER 1 INTRODUCTION ........................................................................... 23 CHAPTER 2 MATERIALS AND METHODS.................................................... 49 CHAPTER 3 MINIMAL FUNCTIONAL ALPHA-SATELLITE DNA............ 69 CHAPTER 4 NEOCENTROMERE CHROMATIN........................................... 89 CHAPTER 5 OVERVIEW AND FUTURE DIRECTIONS
Recommended publications
  • Epigenetic Control of Mammalian Centromere Protein Binding: Does DNA Methylation Have a Role?

    Epigenetic Control of Mammalian Centromere Protein Binding: Does DNA Methylation Have a Role?

    Journal of Cell Science 109, 2199-2206 (1996) 2199 Printed in Great Britain © The Company of Biologists Limited 1996 JCS3386 Epigenetic control of mammalian centromere protein binding: does DNA methylation have a role? Arthur R. Mitchell*, Peter Jeppesen, Linda Nicol†, Harris Morrison and David Kipling MRC Human Genetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK *Author for correspondence (internet [email protected]) †Present address: MRC Reproductive Biology Unit, Edinburgh, UK SUMMARY Chromosome 1 of the inbred mouse strain DBA/2 has a block of minor satellite DNA sequences on chromosome 1. polymorphism associated with the minor satellite DNA at The binding of the CENP-E protein does not appear to be its centromere. The more terminal block of satellite DNA affected by demethylation of the minor satellite sequences. sequences on this chromosome acts as the centromere as We present a model to explain these observations. This shown by the binding of CREST ACA serum, anti-CENP- model may also indicate the mechanism by which the B and anti-CENP-E polyclonal sera. Demethylation of the CENP-B protein recognises specific sites within the arrays minor satellite DNA sequences accomplished by growing of minor satellite DNA on mouse chromosomes. cells in the presence of the drug 5-aza-2′-deoxycytidine results in a redistribution of the CENP-B protein. This protein now binds to an enlarged area on the more terminal Key words: Centromere satellite DNA, Demethylation, Centromere block and in addition it now binds to the more internal antibody INTRODUCTION A common feature of many mammalian pericentromeric domains is that they contain families of repetitive DNA The centromere of mammalian chromosomes is recognised at sequences (Singer, 1982).
  • Cellular and Molecular Signatures in the Disease Tissue of Early

    Cellular and Molecular Signatures in the Disease Tissue of Early

    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
  • Kinetochore Kinesin CENP-E Is a Processive Bi-Directional Tracker of Dynamic Microtubule Tips

    Kinetochore Kinesin CENP-E Is a Processive Bi-Directional Tracker of Dynamic Microtubule Tips

    ARTICLES Kinetochore kinesin CENP-E is a processive bi-directional tracker of dynamic microtubule tips Nikita Gudimchuk1,5, Benjamin Vitre2,5, Yumi Kim2,6, Anatoly Kiyatkin1, Don W. Cleveland2, Fazly I. Ataullakhanov3,4 and Ekaterina L. Grishchuk1,7 During vertebrate mitosis, the centromere-associated kinesin CENP-E (centromere protein E) transports misaligned chromosomes to the plus ends of spindle microtubules. Subsequently, the kinetochores that form at the centromeres establish stable associations with microtubule ends, which assemble and disassemble dynamically. Here we provide evidence that after chromosomes have congressed and bi-oriented, the CENP-E motor continues to play an active role at kinetochores, enhancing their links with dynamic microtubule ends. Using a combination of single-molecule approaches and laser trapping in vitro, we demonstrate that once reaching microtubule ends, CENP-E converts from a lateral transporter into a microtubule tip-tracker that maintains association with both assembling and disassembling microtubule tips. Computational modelling of this behaviour supports our proposal that CENP-E tip-tracks bi-directionally through a tethered motor mechanism, which relies on both the motor and tail domains of CENP-E. Our results provide a molecular framework for the contribution of CENP-E to the stability of attachments between kinetochores and dynamic microtubule ends. Accurate chromosome segregation depends on interactions between proportion of lagging chromosomes in anaphase in mouse liver microtubules and the kinetochore, a protein structure localized at cells and embryonic fibroblasts11,17. Fourth, after CENP-E-mediated each centromere1. Initially, kinetochores often attach to the walls congression, CENP-E-dependent localization of protein phosphatase of microtubules with the chromosomes then moving towards a 1 (PP1) to kinetochores is still required for stable microtubule spindle pole in a dynein-dependent manner2,3.
  • Organization, Evolution and Function of Alpha Satellite Dna

    Organization, Evolution and Function of Alpha Satellite Dna

    ORGANIZATION, EVOLUTION AND FUNCTION OF ALPHA SATELLITE DNA AT HUMAN CENTROMERES by M. KATHARINE RUDD Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Advisor: Dr. Huntington F. Willard Department of Genetics CASE WESTERN RESERVE UNIVERSITY January, 2005 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ______________________________________________________ candidate for the Ph.D. degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. 1 Table of Contents Table of contents.................................................................................................1 List of Tables........................................................................................................2 List of Figures......................................................................................................3 Acknowledgements.............................................................................................5 Abstract................................................................................................................6
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
  • WNT16 Is a New Marker of Senescence

    WNT16 Is a New Marker of Senescence

    Table S1. A. Complete list of 177 genes overexpressed in replicative senescence Value Gene Description UniGene RefSeq 2.440 WNT16 wingless-type MMTV integration site family, member 16 (WNT16), transcript variant 2, mRNA. Hs.272375 NM_016087 2.355 MMP10 matrix metallopeptidase 10 (stromelysin 2) (MMP10), mRNA. Hs.2258 NM_002425 2.344 MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase) (MMP3), mRNA. Hs.375129 NM_002422 2.300 HIST1H2AC Histone cluster 1, H2ac Hs.484950 2.134 CLDN1 claudin 1 (CLDN1), mRNA. Hs.439060 NM_021101 2.119 TSPAN13 tetraspanin 13 (TSPAN13), mRNA. Hs.364544 NM_014399 2.112 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 2.070 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 2.026 DCBLD2 discoidin, CUB and LCCL domain containing 2 (DCBLD2), mRNA. Hs.203691 NM_080927 2.007 SERPINB2 serpin peptidase inhibitor, clade B (ovalbumin), member 2 (SERPINB2), mRNA. Hs.594481 NM_002575 2.004 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 1.989 OBFC2A Oligonucleotide/oligosaccharide-binding fold containing 2A Hs.591610 1.962 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 1.947 PLCB4 phospholipase C, beta 4 (PLCB4), transcript variant 2, mRNA. Hs.472101 NM_182797 1.934 PLCB4 phospholipase C, beta 4 (PLCB4), transcript variant 1, mRNA. Hs.472101 NM_000933 1.933 KRTAP1-5 keratin associated protein 1-5 (KRTAP1-5), mRNA. Hs.534499 NM_031957 1.894 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 1.884 CYTL1 cytokine-like 1 (CYTL1), mRNA. Hs.13872 NM_018659 tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain (TNFRSF10D), 1.848 TNFRSF10D Hs.213467 NM_003840 mRNA.
  • A Free-Living Protist That Lacks Canonical Eukaryotic DNA Replication and Segregation Systems

    A Free-Living Protist That Lacks Canonical Eukaryotic DNA Replication and Segregation Systems

    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.14.435266; this version posted March 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 A free-living protist that lacks canonical eukaryotic DNA replication and segregation systems 2 Dayana E. Salas-Leiva1, Eelco C. Tromer2,3, Bruce A. Curtis1, Jon Jerlström-Hultqvist1, Martin 3 Kolisko4, Zhenzhen Yi5, Joan S. Salas-Leiva6, Lucie Gallot-Lavallée1, Geert J. P. L. Kops3, John M. 4 Archibald1, Alastair G. B. Simpson7 and Andrew J. Roger1* 5 1Centre for Comparative Genomics and Evolutionary Bioinformatics (CGEB), Department of 6 Biochemistry and Molecular Biology, Dalhousie University, Halifax, NS, Canada, B3H 4R2 2 7 Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom 8 3Oncode Institute, Hubrecht Institute – KNAW (Royal Netherlands Academy of Arts and Sciences) 9 and University Medical Centre Utrecht, Utrecht, The Netherlands 10 4Institute of Parasitology Biology Centre, Czech Acad. Sci, České Budějovice, Czech Republic 11 5Guangzhou Key Laboratory of Subtropical Biodiversity and Biomonitoring, School of Life Science, 12 South China Normal University, Guangzhou 510631, China 13 6CONACyT-Centro de Investigación en Materiales Avanzados, Departamento de medio ambiente y 14 energía, Miguel de Cervantes 120, Complejo Industrial Chihuahua, 31136 Chihuahua, Chih., México 15 7Centre for Comparative Genomics and Evolutionary Bioinformatics (CGEB), Department of 16 Biology, Dalhousie University, Halifax, NS, Canada, B3H 4R2 17 *corresponding author: [email protected] 18 D.E.S-L ORCID iD: 0000-0003-2356-3351 19 E.C.T.
  • The Genetic Program of Pancreatic Beta-Cell Replication in Vivo

    The Genetic Program of Pancreatic Beta-Cell Replication in Vivo

    Page 1 of 65 Diabetes The genetic program of pancreatic beta-cell replication in vivo Agnes Klochendler1, Inbal Caspi2, Noa Corem1, Maya Moran3, Oriel Friedlich1, Sharona Elgavish4, Yuval Nevo4, Aharon Helman1, Benjamin Glaser5, Amir Eden3, Shalev Itzkovitz2, Yuval Dor1,* 1Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel 2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. 3Department of Cell and Developmental Biology, The Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel 4Info-CORE, Bioinformatics Unit of the I-CORE Computation Center, The Hebrew University and Hadassah, The Institute for Medical Research Israel- Canada, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel 5Endocrinology and Metabolism Service, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel *Correspondence: [email protected] Running title: The genetic program of pancreatic β-cell replication 1 Diabetes Publish Ahead of Print, published online March 18, 2016 Diabetes Page 2 of 65 Abstract The molecular program underlying infrequent replication of pancreatic beta- cells remains largely inaccessible. Using transgenic mice expressing GFP in cycling cells we sorted live, replicating beta-cells and determined their transcriptome. Replicating beta-cells upregulate hundreds of proliferation- related genes, along with many novel putative cell cycle components. Strikingly, genes involved in beta-cell functions, namely glucose sensing and insulin secretion were repressed. Further studies using single molecule RNA in situ hybridization revealed that in fact, replicating beta-cells double the amount of RNA for most genes, but this upregulation excludes genes involved in beta-cell function.
  • Kinetochore-Microtubule Attachment Throughout Mitosis Potentiated By

    Kinetochore-Microtubule Attachment Throughout Mitosis Potentiated By

    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 Kinetochore-microtubule attachment throughout mitosis potentiated by the elongated stalk of the kinetochore kinesin CENP-E Benjamin Vitre University of California - San Diego Nikita Gudimchuk University of Pennsylvania Ranier Borda University of California - San Diego Yumi Kim University of California - San Diego John E. Heuser Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Vitre, Benjamin; Gudimchuk, Nikita; Borda, Ranier; Kim, Yumi; Heuser, John E.; Cleveland, Don W.; and Grishchuk, Ekaterina L., ,"Kinetochore-microtubule attachment throughout mitosis potentiated by the elongated stalk of the kinetochore kinesin CENP-E." Molecular Biology of the Cell.25,15. 2272-2281. (2014). https://digitalcommons.wustl.edu/open_access_pubs/3207 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Benjamin Vitre, Nikita Gudimchuk, Ranier Borda, Yumi Kim, John E. Heuser, Don W. Cleveland, and Ekaterina L. Grishchuk This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/3207 M BoC | ARTICLE Kinetochore–microtubule attachment
  • The Kinesin Spindle Protein Inhibitor Filanesib Enhances the Activity of Pomalidomide and Dexamethasone in Multiple Myeloma

    The Kinesin Spindle Protein Inhibitor Filanesib Enhances the Activity of Pomalidomide and Dexamethasone in Multiple Myeloma

    Plasma Cell Disorders SUPPLEMENTARY APPENDIX The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma Susana Hernández-García, 1 Laura San-Segundo, 1 Lorena González-Méndez, 1 Luis A. Corchete, 1 Irena Misiewicz- Krzeminska, 1,2 Montserrat Martín-Sánchez, 1 Ana-Alicia López-Iglesias, 1 Esperanza Macarena Algarín, 1 Pedro Mogollón, 1 Andrea Díaz-Tejedor, 1 Teresa Paíno, 1 Brian Tunquist, 3 María-Victoria Mateos, 1 Norma C Gutiérrez, 1 Elena Díaz- Rodriguez, 1 Mercedes Garayoa 1* and Enrique M Ocio 1* 1Centro Investigación del Cáncer-IBMCC (CSIC-USAL) and Hospital Universitario-IBSAL, Salamanca, Spain; 2National Medicines Insti - tute, Warsaw, Poland and 3Array BioPharma, Boulder, Colorado, USA *MG and EMO contributed equally to this work ©2017 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2017.168666 Received: March 13, 2017. Accepted: August 29, 2017. Pre-published: August 31, 2017. Correspondence: [email protected] MATERIAL AND METHODS Reagents and drugs. Filanesib (F) was provided by Array BioPharma Inc. (Boulder, CO, USA). Thalidomide (T), lenalidomide (L) and pomalidomide (P) were purchased from Selleckchem (Houston, TX, USA), dexamethasone (D) from Sigma-Aldrich (St Louis, MO, USA) and bortezomib from LC Laboratories (Woburn, MA, USA). Generic chemicals were acquired from Sigma Chemical Co., Roche Biochemicals (Mannheim, Germany), Merck & Co., Inc. (Darmstadt, Germany). MM cell lines, patient samples and cultures. Origin, authentication and in vitro growth conditions of human MM cell lines have already been characterized (17, 18). The study of drug activity in the presence of IL-6, IGF-1 or in co-culture with primary bone marrow mesenchymal stromal cells (BMSCs) or the human mesenchymal stromal cell line (hMSC–TERT) was performed as described previously (19, 20).
  • Evolutionarily Conserved Protein ERH Controls CENP-E Mrna Splicing and Is Required for the Survival of KRAS Mutant Cancer Cells

    Evolutionarily Conserved Protein ERH Controls CENP-E Mrna Splicing and Is Required for the Survival of KRAS Mutant Cancer Cells

    Evolutionarily conserved protein ERH controls CENP-E PNAS PLUS mRNA splicing and is required for the survival of KRAS mutant cancer cells Meng-Tzu Wenga,b,c, Jih-Hsiang Leea, Shu-Chen Weid, Qiuning Lia, Sina Shahamatdara, Dennis Hsua, Aaron J. Schettere, Stephen Swatkoskif, Poonam Mannang, Susan Garfieldg, Marjan Gucekf, Marianne K. H. Kima, Christina M. Annunziataa, Chad J. Creightonh, Michael J. Emanuelei, Curtis C. Harrise, Jin-Chuan Sheud, Giuseppe Giacconea, and Ji Luoa,1 aMedical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; bGraduate Institute of Clinical Medicine, National Taiwan University, Taipei 100, Taiwan; cFar-Eastern Memorial Hospital, Taipei 220, Taiwan; dDepartment of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei 100, Taiwan; eLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; fProteomics Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892; gConfocal Microscopy Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; hDepartment of Medicine and Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX 77030; and iDepartment of Genetics, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA 02115 Edited by Bert Vogelstein, Johns Hopkins University, Baltimore, MD, and approved November 12, 2012 (received for review June 1, 2012) Cancers with Ras mutations represent a major therapeutic prob- anaphase-promoting complex (APC/C) that coordinately maintain lem. Recent RNAi screens have uncovered multiple nononcogene the fidelity of chromosome segregation (6). Symmetrical distribu- addiction pathways that are necessary for the survival of Ras mu- tion of chromosomes during mitosis is critical for genomic stability tant cells.
  • Satellite DNA at the Centromere Is Dispensable for Segregation Fidelity

    Satellite DNA at the Centromere Is Dispensable for Segregation Fidelity

    G C A T T A C G G C A T genes Brief Report Satellite DNA at the Centromere Is Dispensable for Segregation Fidelity Annalisa Roberti, Mirella Bensi, Alice Mazzagatti, Francesca M. Piras, Solomon G. Nergadze , Elena Giulotto * and Elena Raimondi * Department of Biology and Biotechnology “L. Spallanzani”, University of Pavia, Via Ferrata 1, 27100 Pavia, Italy; [email protected] (A.R.); [email protected] (M.B.); [email protected] (A.M.); [email protected] (F.M.P.); [email protected] (S.G.N.) * Correspondence: [email protected] (E.G.); [email protected] (E.R.) Received: 7 June 2019; Accepted: 19 June 2019; Published: 20 June 2019 Abstract: The typical vertebrate centromeres contain long stretches of highly repeated DNA sequences (satellite DNA). We previously demonstrated that the karyotypes of the species belonging to the genus Equus are characterized by the presence of satellite-free and satellite-based centromeres and represent a unique biological model for the study of centromere organization and behavior. Using horse primary fibroblasts cultured in vitro, we compared the segregation fidelity of chromosome 11, whose centromere is satellite-free, with that of chromosome 13, which has similar size and a centromere containing long stretches of satellite DNA. The mitotic stability of the two chromosomes was compared under normal conditions and under mitotic stress induced by the spindle inhibitor, nocodazole. Two independent molecular-cytogenetic approaches were used—the interphase aneuploidy analysis and the cytokinesis-block micronucleus assay. Both assays were coupled to fluorescence in situ hybridization with chromosome specific probes in order to identify chromosome 11 and chromosome 13, respectively.